# Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

> **NCT06919081** · PHASE2 · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 24 (estimated)

## Conditions studied

- Persistent Corneal Epithelial Defect
- Corneal Epithelial Disorders

## Interventions

- **DRUG:** Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome
- **OTHER:** Vehicle Control

## Key facts

- **NCT ID:** NCT06919081
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-06-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919081, "Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06919081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*